Literature DB >> 17328572

Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp.

Roger G Linington1, José Gonzalez, Luis-David Ureña, Luz I Romero, Eduardo Ortega-Barría, William H Gerwick.   

Abstract

Two new modified cyclic hexapeptides, venturamides A (1) and B (2), were isolated from the marine cyanobacterium Oscillatoria sp. by antimalarial bioassay-guided fractionation. The isolation of 1 and 2 represents the first example of the identification of cyanobacterial peptides with selective antimalarial activity. The planar structures of 1 and 2 were determined by 1D and 2D NMR analyses and, in the case of venturamide A (1), comparison with the literature data for a previously reported synthetic compound. The absolute configuration of the amino acid residues was determined by selective hydrolysis in conjunction with Marfey's analysis. Compounds 1 and 2 were tested for biological activity against a range of tropical parasites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328572     DOI: 10.1021/np0605790

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  34 in total

1.  Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp.

Authors:  Roger G Linington; Daniel J Edwards; Cynthia F Shuman; Kerry L McPhail; Teatulohi Matainaho; William H Gerwick
Journal:  J Nat Prod       Date:  2007-12-29       Impact factor: 4.050

2.  Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2015-05-01       Impact factor: 3.641

3.  Phylogenetic inferences reveal a large extent of novel biodiversity in chemically rich tropical marine cyanobacteria.

Authors:  Niclas Engene; Sarath P Gunasekera; William H Gerwick; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

Review 5.  Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.

Authors:  Kaarina Sivonen; Niina Leikoski; David P Fewer; Jouni Jokela
Journal:  Appl Microbiol Biotechnol       Date:  2010-02-27       Impact factor: 4.813

Review 6.  Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic.

Authors:  Florie Desriac; Diane Defer; Nathalie Bourgougnon; Benjamin Brillet; Patrick Le Chevalier; Yannick Fleury
Journal:  Mar Drugs       Date:  2010-04-04       Impact factor: 5.118

Review 7.  Marine antimalarials.

Authors:  Ernesto Fattorusso; Orazio Taglialatela-Scafati
Journal:  Mar Drugs       Date:  2009-04-23       Impact factor: 5.118

Review 8.  Thiazole and oxazole alkaloids: isolation and synthesis.

Authors:  Danilo Davyt; Gloria Serra
Journal:  Mar Drugs       Date:  2010-11-05       Impact factor: 5.118

9.  Phylogenetic and chemical diversity of three chemotypes of bloom-forming lyngbya species (Cyanobacteria: Oscillatoriales) from reefs of southeastern Florida.

Authors:  Koty Sharp; Karen E Arthur; Liangcai Gu; Cliff Ross; Genelle Harrison; Sarath P Gunasekera; Theresa Meickle; Susan Matthew; Hendrik Luesch; Robert W Thacker; David H Sherman; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

10.  Antineoplastic agents. 570. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris.

Authors:  George R Pettit; John C Knight; Delbert L Herald; Robin K Pettit; Fiona Hogan; Venugopal J R V Mukku; John S Hamblin; Michael J Dodson; Jean-Charles Chapuis
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.